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Abstract
Background:  Large-scale statistical analyses have become hallmarks of post-genomic era
biological research due to advances in high-throughput assays and the integration of large biological
databases. One accompanying issue is the simultaneous estimation of p-values for a large number
of hypothesis tests. In many applications, a parametric assumption in the null distribution such as
normality may be unreasonable, and resampling-based p-values are the preferred procedure for
establishing statistical significance. Using resampling-based procedures for multiple testing is
computationally intensive and typically requires large numbers of resamples.
Results: We present a new approach to more efficiently assign resamples (such as bootstrap
samples or permutations) within a nonparametric multiple testing framework. We formulated a
Bayesian-inspired approach to this problem, and devised an algorithm that adapts the assignment
of resamples iteratively with negligible space and running time overhead. In two experimental
studies, a breast cancer microarray dataset and a genome wide association study dataset for
Parkinson's disease, we demonstrated that our differential allocation procedure is substantially
more accurate compared to the traditional uniform resample allocation.
Conclusion: Our experiments demonstrate that using a more sophisticated allocation strategy
can improve our inference for hypothesis testing without a drastic increase in the amount of
computation on randomized data. Moreover, we gain more improvement in efficiency when the
number of tests is large. R code for our algorithm and the shortcut method are available at http://
people.pcbi.upenn.edu/~lswang/pub/bmc2009/.
Background
Nonparametric tests in multiple hypothesis testing 
scenarios
Large-scale statistical analyses have become hallmarks of
post-genomic era biological research due to advances in
high-throughput assays and the integration of large bio-
logical databases. As the analysis becomes larger and more
complex, various kinds of computational issues arise. The
context of our investigation is multiple testing, the simulta-
neous estimation of p-values for a large number of
hypothesis tests. For example, in a typical control-treat-
ment microarray experiment, the goal of the analysis may
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be to identify target genes by applying the same testing
procedure on each of the genes and selecting those that
show the most extreme differential expression.
Most multiple testing scenarios involve the assumption of
a parametric null distribution (such as the normal or t dis-
tribution) for each observed test statistic. However, in
many applications, this parametric assumption may be
unreasonable, resampling-based p-values are the pre-
ferred procedure for establishing statistical significance.
For example, in the usual permutation test framework,
resamples are generated by randomly permuting the treat-
ment and control labels among the available data sam-
ples. We then calculate the test statistic for each of these
resamples and calculate the p-value for each gene as the
fraction of the resamples that have more extreme test sta-
tistics than the observed test statistic for that gene. Ideally,
we would be able to evaluate the test statistic for every
possible resample, and thus calculate the resample-based
p-value exactly. However, this is usually not feasible for
datasets involving many replicates, so the usual procedure
is to use Monte Carlo simulation to estimate each p-value
based on a large set of resamples. As an example, an
option in the popular SAM microarray analysis software
[1] allows the user to use permutation tests to assess the p-
value without the normality assumption. A similar re-
sampling scheme for estimating p-values can be based on
the bootstrap. In [2], a nonparametric test procedure is
applied to every gene to examine how well the expression
profile of a gene (say over a time course) fits some preset
order-restrictions; the p-value of the test is obtained using
50000 bootstrap resamples per gene. We refer the reader to
[3,4] for the rationale and more details on bootstrapping,
permutation tests, and other nonparametric tests. In this
paper we collectively refer these methods as resampling
procedures and a randomly generated sample (whether
bootstrap or permutation-based) is called a resample.
This paper focusses on the following setting: we have N
units (eg. genes), and we want to conduct a hypothesis
test for each gene i based on observed test statistic Ti. We
do not want to make any parametric assumptions about
this test statistic, so the p-value pi for each test needs to be
estimated by a resampling procedure. The additional ele-
ment that is implicit in our framework is that the number
of tests N is large (can be as high as 106 for genome-wide
association studies), so we need to control for the large
number of tests being performed. Many multiple testing
procedures focussed on control of the family-wise error rate
(FWER), with a popular choice being the Bonferroni cor-
rection [5]. More recently, the focus in multiple testing
procedures has shifted to control of the false discovery rate
(FDR) [6-8], which is much less conservative than FWER-
control procedures. Since this current work was motivated
by biological applications, we will use the terms gene and
unit  interchangebly, with the understanding that our
methods are applicable to any multiple testing situation.
Typical Uniform Resampling Strategies
Typical resampling procedures for p-value estimation use
an equal number of resamples, say B, assigned to each of
N genes, for a total of N × B resamples. Even in the simple
framework where each gene will be assigned the same
number of resamples, there are several alternative strate-
gies for resampling-based inference. The first issue is
whether each resample should be performed by randomly
permuting the treatment and control labels of an entire
column (across all genes) of data values, with the alterna-
tive being that treatment and control labels are permuted
within each gene independently. We refer to the first strat-
egy as a column-wise procedure and the second strategy as
an gene-independent procedure. Many recent investigations
(eg. [9-11]) argue for column-wise resampling procedures
in order to retain potential dependencies between genes.
Other recent microarray investigations (eg. [12]) have
employed gene-independent resampling procedures.
Clearly, a column-wise resampling procedure allocates
resamples to all genes simultaneously, which implies a
uniform allocation of resamples across genes. Although
this column-wise strategy is preferred in certain situations,
it suffers from the same inefficiencies as any uniform allo-
cation procedure: genes that are clearly distant from the
decision threshold will receive the same number of resa-
mples as genes that are quite near the threshold. We focus
on a gene-independent resampling procedure since it pro-
vides a more flexible framework for differential allocation
of resamples among genes, which is the primary motiva-
tion for our current work.
Another issue is whether or not to combine resampled test
statistics across genes when estimating the p-value for
each gene. Many researchers (eg. [7]) prefer a concatenation
procedure that uses all available resampled test statistics
(across all genes) to achieve a higher resolution on the
resampling-based null distribution when estimating each
p-value. Since all resampled test statistics (across all
genes) are used for each p-value calculation, there is little
distinction between resampling strategies based on uni-
form allocation of resamples across genes versus differen-
tial allocation of resamples across genes. However, a
concatenation procedure is only reasonable when the
resampling-based null distribution is similar across genes,
which is an uncomfortable assumption in many applica-
tions, such as genome-wide association studies when the
allelic frequencies vary across loci. In these applications, a
non-concatenation or gene-separate procedure would be
preferred. Recent work (eg. [13,14]) proposes concatena-
tion of statistics across only subsets of genes to correct for
the fact that the null distribution is likely to differ between
significant and non-significant genes. In this paper, weBMC Bioinformatics 2009, 10:198 http://www.biomedcentral.com/1471-2105/10/198
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will focus on situations where gene-separate (non-concate-
nation) procedures are preferred, which is the area where
differential allocation of resamples provides a substantial
efficiency gain over a uniform allocation strategy.
In most multiple testing situations the vast majority of
units are truly non-significant, which means that a uni-
form allocation strategy is devoting a large proportion of
resamples to test statistics that are not even close to signif-
icant. For most estimated p-values that are quite large or
extremely small (ie. far away from our decision threshold
p0), then we are reasonably confident about our decision
based on those p-values without need for a high degree of
p-value accuracy (large number of resamples). Instead, we
should focus a larger number of resamples on the estima-
tion of p-values that are near to our decision-making
threshold. For example, one may limit the number of resa-
mples for a gene when the number of resamples with test
statistic exceeding the actual statistic is larger than p0 × B,
since the p-value of this gene will definitely be higher than
the threshold p0 when all B resamples are computed. The
gene is clearly nonsignificant, so we can stop evaluating
more resamples for this gene and save computational
time. This simple heuristic, which we call the shortcut
approach, has been discussed previously [15] and imple-
mented more recently in the popular software PLINK [16].
In this paper, we develop a principled iterative procedure
for allocating different numbers of resamples to each unit.
The overall intuition behind our approach is similar to the
shortcut method in that we want to preferentially allocate
more resamples to genes which have "borderline" p-val-
ues, i.e., p-values near to our classification threshold. The
main difference is how the resample allocations are deter-
mined: we use a Bayesian-inspired approach that assigns
resamples to each unit based on its individual "risk", the
chance that the current p-value estimate leads to a misclas-
sification of the unit. The goal is to lower the numbers of
classification errors, since we are giving a higher resolu-
tion to the null distribution of genes that are more likely
to be misclassified in a uniform allocation setting. This
higher resolution comes at the sacrifice of resamples to
non-borderline genes that should not need a very resolute
null distribution for correct inference.
A detailed description of our differential allocation proce-
dure is provided in the Methods section. The Results Sec-
tion includes an experimental comparison that
demonstrates the gains of our procedure over uniform
procedures using two publicly available datasets: one
microarray dataset on breast cancer [17], and one
genome-wide association study [18] where computa-
tional efficiency in p-value estimation is a necessary con-
cern due to its size. Our procedure maintains a low error-
rate (low rates of false positives and false negatives) while
using substantially fewer resamples in total. We then pro-
vide an additional experimental comparison to demon-
strate that our method outperforms the shortcut method.
Methods
Differential Allocation of Resamples Using Risks
We separate the description of our procedure into several
subsections for clarity of presentation.
Algorithm Initialization
The input data for our algorithm is an N × J matrix of data
values, where N  is the number of genes and J  is the
number of observations per gene. Our algorithm is initial-
ized by a uniform allocation burn-in round, in which we
assign B0 resamples to each gene, where B0 is a proportion
of the B resamples that would be assigned to each gene by
the typical uniform resampling procedure. Each of these
resamples gives us a test statistic under the resampling-
based null distribution, which we can use to get an initial
p-value estimate for each gene.
Based on the given threshold p0 and our current estimated
p-values  , we have the current classification for each
gene i: gene i is significant if   ≤ p0 or gene i is non-sig-
nificant if   > p0. In case when p0 is determined using
other criterion such as FDR, we use these p-value estimates
to calculate our decision threshold p0 using the original
FDR-control procedure proposed by [19].
Differential Allocation
Our algorithm now proceeds sequentially through multi-
ple rounds and in each round a total of K new resamples
are assigned. We want to allocate new resamples differen-
tially to each gene i  with the goal of minimizing the
expected number of mis-classified genes ie. either non-sig-
nificant genes that are inferred to be significant (false pos-
itives) or significant genes that are inferred to be non-
significant (false negatives). Our framework treats either
type of error (false-positives vs. false-negatives) as equally
bad, though our approach could be easily generalized to
differentially weight the two types of errors. Our proposed
strategy is to assign new resamples with probability pro-
portional to the risk Ri of each gene i: the current probabil-
ity of that gene i being misclassified.
where pi represents the true p-value for gene i. Only one of
these two terms is non-zero, since any gene i can only be
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considered as either a false positive or false negative (not
both) based on its current estimated p-value  . We esti-
mate the probabilities P(pi ≤ p0) and P(pi > p0) based on
the posterior distribution of p-value pi for gene i. Let ni be
the number of resamples already performed on gene i and
let ai be the number of resample test statistics that are
more extreme than the observed test statistic for gene i.
This pair of numbers (ai, ni) contains all the information
we currently have for gene i. Assuming a uniform prior on
each pi, pi ~ Beta(1, 1), and with a binomial likelihood for
our extreme resample counts ai ~ Bin(ni, pi), then we have:
so each probability Ri becomes
where B(x, a, b) is the CDF of the Beta(a, b) distribution
evaluated at x. B(x, a, b) is often also referred to as the
incomplete Beta function. In Figure 1, we see the risk for dif-
ferent locations of the posterior distribution p(pi|ai, ni).
This illustration shows that the risk Ri is the amount by
which the posterior distribution (1) for gene i overlaps the
significance threshold p0.
After the end of each round, K new resamples have been
assigned proportional to the risks given in (2), and for
each affected gene, the new p-value pi and the risk Ri must
be calculated. The algorithm stops when the total number
of resamples assigned reaches a preset cap Btot. We should
note that the above scheme considers the decision thresh-
old p0 to be fixed and known, when it is actually itself an
estimated quantity. A more general procedure that
acknowledges the uncertainty in both the p-values pi and
decision threshold p0 for FDR is the focus of continuing
research. We provide a more detailed description of our
proposed differential allocation algorithm below.
Input: Microarray measurements gi = (gi1, ... giJ) for each
gene i, 1 ≤ i ≤ N.
Output: Set of significant genes as defined by threshold
p0.
Parameters
1. B0: number of reseamples per gene for burn-in.
2. B: average number of resamples to allocate per gene,
so that N × B is total number of resamples to be used.
3. K: number of resamples allocated in each round.
Algorithm
1. For each gene i, compute observed test statistic fi = f
(gi).
2. Burn-in Allocation: ni ← B0
3. Iterative Allocation: Repeat:
(a) For each gene i, calculate ai = number of ni resa-
mples with test statistic ≥ fi and set   = ai/ni
(b) For each gene i, compute Ri ← B(p0, ai + 1, ni -
ai + 1). If pi ≥ p0 then set Ri ← 1 - Ri.
(c) For each gene i, compute wi = Ri/ΣiRi.
(d) While j <K:
i. Select a gene b from the set (1, 2, ... N) with
probability (w1, w2, ..., wN)
ii. Assign a resample to selected gene b: nb ← nb
+ 1
iii. j ← j + 1
ˆ pi
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Sample figure title Figure 1
Sample figure title. Illustration of the risks associated with 
two different p-values. The red density is the posterior distri-
bution of p-value p1. The blue density is the posterior distri-
bution of p-value p2. The decision threshold for assessing 
significance is denoted as p0. The risk R1 (associated with p-
value p1) is the red area on the right of the decision thresh-
old p0. The risk R2 (associated with p-value p2) is the blue 
area on the left of the decision threshold p0.
R1
R2
p0 p1 p2BMC Bioinformatics 2009, 10:198 http://www.biomedcentral.com/1471-2105/10/198
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4. Output the set of significant genes by applying
threshold p0 on final set of { }.
The Shortcut Method
An alternative differential allocation idea that we call the
the shortcut method is to stop allocating resamples to any
genes which have already accumulated enough non-
extreme test statistics to guarantee that the null hypothesis
for those genes will not be rejected. [15] discuss a sequen-
tial shortcut method for Monte Carlo estimation of p-val-
ues and more recently a shortcut method has been
implemented in [20]. The popular software PLINK [16]
for genome-wide association studies allows for more
sophisticated approaches, such as using a confidence
interval of the estimated p-value of a unit to decide if
more resamples are needed.
Again let N  be the number of genes and let B  be the
number of resamples that we would allocate to each gene
in a uniform allocation scheme, so that we have a total of
N × B resamples available to us. We again consider an iter-
ative scheme where ni is the number of resamples already
performed for gene i and let ai is the number of resample
test statistics that are more extreme than the observed test
statistic for gene i. If a particular gene i has accumulated
enough non-extreme resample test statistics, i.e. if (ni - ai)
> B·p0, then the resampling-based p-value   is guaran-
teed to exceed the threshold p0 and so allocating any more
resamples to gene i is pointless. All remaining (B - ni) resa-
mples that we would have devoted to gene i can now be
allocated to other genes that still have a chance of reject-
ing the null hypothesis. This shortcut approach clearly dif-
fers from our proposed method in terms of how
resamples are differentially allocated, but both should
still be more efficient than a uniform allocation scheme.
Another major difference is that our differential allocation
method will also assign fewer resamples to genes when
the p-value is much lower than the cutoff, whereas the
shortcut method always tends to allocate more resamples
to genes with a lower p-value.
Experimental Comparision
Application to a breast cancer microarray dataset
The Hedenfalk et al. breast cancer dataset [17] consisted of
7 sporadic cases, 7 cases with BRCA1 mutations, and 8
cases with BRCA2 mutations. Following the guidelines in
[7], we only examine samples associated with either
BRCA1 and BRCA2 mutations, which results in 8 samples
for BRCA1 and 7 samples for BRCA2. Following the pre-
processing procedure in [7], we log2-transformed all
measurements and removed outlier genes (defined as
genes having any expression level above 20 in [7]); this
left us with 3170 genes for further analysis. The subjects
were divided into two groups. For each gene, we tested
whether the mean expression levels of the two groups are
significantly different. We used the absolute value of the
Student's t-statistic and used permutation tests to com-
pute the significance: the p-value of the gene is the frac-
tion of random permutation resamples with larger
statistic scores than the correct grouping of subjects. We
varied the number of resamples per gene to see how the p-
value estimation of our algorithm and the uniform alloca-
tion improved as the number of resamples increased. We
assessed the accuracy by computing, as a reference, the
exact p-values calculated by enumerating all   = 6435
possible resamples for each gene. The error of any p-value
estimation is the number of genes mislabeled as signifi-
cant or nonsignificant when compared with the signifi-
cance calls using these reference exact p-values and a
significance threshold of 0.0001. All computations were
done using the R statistical software [21].
Application to a Parkinson disease genome-wide 
association study dataset
The Parkinson's dataset [18] consisted of the genotype
information of 402,582 SNPs on 271 cases and 270 con-
trols. We randomly partitioned the dataset into 30 subsets
of 13,626 SNPs each on average, and applied our algo-
rithm to each subset separately. For each SNP, we used the
chi-square statistic for the 3 × 2 contingency table, and
computed the exact chi-square test p-value with 2 degrees
of freedom as the "reference" p-value. We also applied our
differential allocation algorithm by setting B = 1000, B0 =
100, 250, 500, 1000 (uniform allocation), and p0 = 10-4 in
the differential allocation algorithm. We then computed
the accuracy and false discovery rate of the output from
the four allocation algorithms using different p-value cut-
offs; the "reference" set of significant SNPs were deter-
mined using the "reference" p-value using the same p-
value cutoff.
Simulation study to compare our algorithm and the shortcut method
We compared our method and the shortcut method using
the following parameter settings:
1. We use N = 300, 000, typical for genome-wide asso-
ciation studies. The actual p-values of all markers are
generated as follows. First, for each marker we ran-
domly sample an integer between 1 and N; the p-value
ˆ pi
ˆ pi
15
7
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è
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ø
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of the marker is this number divided by N. Thus each
marker will have a p-value between 1/N and 1 at this
moment. We then replace the p-values of five of the
markers by 10-7 to represent real significant markers.
2. For both methods, we use the same p-value cutoff
settings:
10-5, 2 × 10-5, 5 × 10-5, 10-4, 2 × 10-4, 5 × 10-4, 10-3.
3. For the shortcut method, each iteration allocates B
= 10 resamples. The algorithm stops when the average
number of resamples per marker exceed 100.
4. We use a simplified version of the adaptive permu-
tation algorithm in PLINK, a program widely used in
the analysis of genome-wide association studies [16].
At each iteration, the p-value estimate of marker i is  ˆ pi
Sample figure title Figure 2
Sample figure title. Area under ROC curve (AUC), Error (defined as (FN+FP)/(P+N)), and false discovery rate (FDR) of the 
uniform (B/B0 = 1) and differential allocation algorithms using the Hedenfalk et al. gene expression dataset. Left: p-value cutoff = 
0.001; right: p-value cutoff = 0.005.
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= (1 + Di)/(2 + Fi), where Fi is the total resamples allo-
cated to i so far, and Di is the number of such resam-
ples that yield higher statistics than the actual statistic
(this is determined in the simulation by Bernoulli tri-
als with success probability pi). This   estimate is
equivalent to the posterior mean when assuming a
uniform prior distribution, and improves upon the
poor performance [22] of the usual estimate   = Di/
Fi when Di = 0. If the actual p-value cutoff p0 is outside
the c-level confidence interval for pi then marker i will
not be included for resample allocation in the next
round. The confidence interval is approximated by a
normal distribution with mean   and standard devi-
ation .  We  use  c = 0.01,0.05, 0.1, 0.3,
0.5 in our simulation.
5. For our algorithm, B0 = K = 10, B = 100.
Results and Discussion
Experimental Validation
We applied our algorithm to two different datasets to
check how efficient it is compared with the conventional
uniformly-allocated re-sampling. The first dataset is a
publicly available microarray dataset to detect genes dif-
ferentially expressed across two conditions. The second,
much larger dataset, is a publicly-available genome-wide
assocation study on Parkinson's disease [18].
Application to a breast cancer microarray dataset
Our algorithm was first applied to the microarray dataset
presented in [17]. The details of preprocessing and appli-
cation of the algorithm to this data are presented in the
Methods Section. The results are in Figure 2. We observe
that in the microarray dataset, the differential allocation
algorithm (B0/B < 1) outperforms the uniform allocation
algorithm (B0/B  = 1) substantially, though the gap
becomes smaller when B increases. We also measured the
areas under ROC curve to eliminate the effect of selecting
a particular threshold of significance, and observed the
same trends (data not shown). In both datasets, the choice
of burn-in proportion B0/B for the differential allocation
algorithm did not seem to affect the performance of the
algorithm.
Application to a Parkinson disease genome-wide association study 
dataset
The results from the previous section suggest our algo-
rithm has the best improvement over the uniform alloca-
tion when the number of possible resamples is relatively
small. In this section, we test our algorithm on a publicly-
available genome-wide association study where the
number of possible resamples is relatively large. Typical
datasets in genome-wide association (GWA) studies may
consist of several thousand case and control subjects each,
using single nucleotide polymorphism (SNP) genotyping
arrays that can genotype up to 106 SNPs. The most com-
mon goal of a genome-wide association study is to find
SNP(s) that are highly correlated with the case/control sta-
tus. One simple way to test the association is to run chi-
square tests on the two-way 3 × 2 contingency table
between the genotype of each SNP (zero, one, or two cop-
ies of the minor allele) and the case-control status [23].
Existence of such SNPs suggests nearby genomic regions
may carry significant genes, regulatory motifs, or other
DNA sequences that may affect the disease risk.
This setting is an important test of computationally effi-
cient resampling-based procedures for several important
reasons. First, the high number of SNPs being tested
implies a very stringent p-value threshold if we take the
issue of multiple testing into consideration: setting p-
ˆ pi
ˆ pi
ˆ pi
ˆ ( ˆ )/ ppF iii 1-
Sample figure title Figure 3
Sample figure title. Error (defined as (FN+FP)/(P+N)) and 
false discovery rate of the uniform (B/B0 = 1) and differential 
allocation algorithms using the public Parkinson Disease 
genome-wide association study dataset.
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value cutoff at 10-5 or lower is typical, so any resampling-
based p-value computation for each SNP requires at least
105 resamples if uniform allocation is used. Second, the
high number of subjects means evaluating the test statistic
for each resample is more costly. Finally, although we
focus on simple chi-square tests as a proof of concept for
our procedure, even more complex and computational
demanding tests that may involve interactions between
multiple SNPs and pedigree information relating subjects
are being actively developed and applied to improve the
sensitivity of GWA studies. As a example, it is common to
consider the maximum p-value between multiple tests,
such as an allelic test and a genotypic test, in a GWA anal-
ysis. These tests may employ statistics that are computa-
tionally expensive, and p-values have to be evaluated
using resampling if exact p-value formulas are not availa-
ble.
As an illustration of our procedure in this difficult setting,
we applied our algorithm to a public Parkinson genome-
wide association study dataset [18]. Refer to the Methods
Section on details of the dataset and the application of our
algorithm. The results are summarized in Figure 3. Notice
that our procedure has excellent accuracy and false discov-
ery rate: at most 20% except when the p-value cutoff is 5
× 10-5. Moreover, the proportion of "burn-in" permuta-
tion resamples has little effect on the accuracy of the dif-
ferential allocation algorithm, probably because the
Sample figure title Figure 4
Sample figure title. FN, FP, and Average Error (defined as (FN+FP)/2) of the shortcut and our differential allocation algo-
rithm (bayesian) in our simulation study. The value c in the legend is the level of confidence interval used in the shortcut 
method; see text for more details.
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enormous number of total SNPs implies there are always
enough resamples from nonsignificant SNPs to be reallo-
cated when needed. Nonuniform allocation always out-
performs uniform allocation by a substantial amount.
Since B = 1000, for p-value thresholds lower than 10-4
only SNPs with 0 as their estimated p-values can pass the
threshold under the uniform allocation. The uniform
allocation algorithm has much higher error and false dis-
covery rate because p-value estimation for significant and
borderline SNPs is less accurate, and the situation is not
improved even when the p-value threshold increases to
10-3.
Simulation comparison to shortcut method
In addition to demonstrating increased efficiency over a
uniform allocation scheme, we also evaluate our method
against the shortcut method, which is also described in
our Methods section. We use N = 300, 000 markers, typi-
cal for genome-wide association studies. We generate the
"actual" 300,000 p-values following a uniform distribu-
tion since we know that the p-values of all (but a few)
markers should be uniformly distributed in a well-
designed genome-wide association study where no con-
founding factors such as population stratification exist.
We evaluate our performance relative to the shortcut
method using simulated p-values directly. See the Meth-
ods section on details of the simulation.
Please see Figure 4 for the results of the simulation. As can
be seen, our method consistently outperforms the short-
cut method. Note that as we increase the p-value cutoff,
the FN rate increases and the FP rate decreases for the
shortcut method. Moreover, when the value of confidence
level  c  increases in the shortcut method, the FP rate
decreases but the FN rate varies in a more complex pattern
affected by both the confidence level c and p0. Small val-
ues of c in the shortcut method has good FN rate in gen-
eral (and outperforms the bayesian method for p0 = 10-4
and 2 × 10-4, but the FP rate is too high. On the other
hand, a large setting of c has good FP rate and bad FN rate.
These observations hint that a symmetric test for both FP
and FN in the shortcut method may be suboptimal (using
the same value of c, level of confidence interval for both
FP and FN scenarios) and an asymmetric approach such as
our algorithm is preferred. Another contributing factor is
that our approach is more global in the sense of allocating
resamples proportional to the risks across all markers as
opposed to the shortcut approach that treats each marker
independently of the progression of other markers.
Running time
We explored the overhead associated with our differential
allocation approach and found it to be negligible on a
modern computer. We computed the running time of the
shortcut method and our differential allocation algorithm
for 5 repetitions of our simulation involving 300,000
SNPs on a dual-quad-core Xeon linux server using R (64-
bit version 2.8.1; our implementation is single-threaded
and no parallelization is involved). Since the permutation
tests in this simulation are generated by random p-values,
the running time is almost entirely a function of the over-
head of the allocation algorithms, not the individual sta-
tistical tests. The average running time of shortcut method
in this situation was about 3.5 minutes, and the average
running time of our algorithm was 1 minute, suggesting
that neither method has substantial overhead. Certainly
in a situation with more complex individual statistical
tests, the running time of either approach will be domi-
nated by the unavoidable calculations of each test statis-
tic.
Conclusion
In this paper we presented a new approach to more effi-
ciently assign resamples (such as bootstrap samples or
permutations) within a nonparametric multiple testing
framework. We formulated a Bayesian-inspired approach
to this problem, and devised an algorithm that adapts the
assignment of resamples iteratively with negligible space
and running time overhead. In two experimental studies,
a breast cancer microarray dataset and a genome wide
association study dataset for Parkinson's disease, we dem-
onstrated that our differential allocation procedure is sub-
stantially more accurate compared to the traditional
uniform resample allocation. In a simulation study we
showed our algorithm outperforms the simpler shortcut
method under various settings. It is worth emphasizing
that our methodology is not ideally suited for the accurate
estimation of all p-values, especially p-values far from the
significance threshold (in either direction). Rather, our
methodology focusses on the accuracy of significance
decisions by ensuring that p-values near the decision
threshold are most accurately estimated.
The idea of using a non-uniform search among a large
number of tests is quite common in other multiple testing
situations. An example is efficient variable selection in
regression models where the number of covariates is very
large. Similar applications can also be found elsewhere: in
finance, [24] used a stepwise regression procedure to pre-
dict bankruptcy, where significant predictors are added
(from a large pool of possible predictors) sequentially
using a procedure where there is differential allocation for
the threshold of significance. Techniques such as this are
different from our situation since we are taking a non-par-
ametric approach to a simpler testing situation, but we
still share the similar idea that one can gain power by dif-
ferentially allocating resources towards the tests that are
most likely to be significant. When individual tests are
simple to compute, e.g., Fisher's exact test on small con-
tingency tables when the p-value can be computed
exactly, the gain by our algorithm or other differential
allocation methods is limited. However, a differentialPublish with BioMed Central    and   every 
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allocation approach is much more important when more
computationally intensive tests are used, such as in Gene
Set Enrichment Analysis [25], or family-based association
tests in genome-wide association studies [26].
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